Amgen Inc.
AMGN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $36.8B | $33.4B | +10.0% |
| Operating income | $9.08B | $7.26B | +25.1% |
| Net income | $7.71B | $4.09B | +88.5% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $10.4B | $9.56B | +8.5% |
| Operating income | $3.71B | $2.53B | +46.9% |
| Net income | $3.86B | $3.22B | +20.1% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Amgen's revenue in FY2025?
- $36.8B in FY2025 (Fiscal year ended Dec 31, 2025), +10.0% vs $33.4B a year earlier, per its 10-K filed Feb 2026.
- Was Amgen profitable in FY2025?
- Yes: net income was $7.71B and operating income $9.08B in FY2025.
- What was Amgen's revenue in Q3 2026?
- $10.4B (+8.5% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.